Reader View AI Reader View Spero Therapeutics COO Timothy Keutzer to retire at year-end, will serve as consultant www.investing.com · October 27, 2026 · 21:31 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link